|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.20 CHF | -2.96% |
|
-2.60% | +7.38% |
| Apr. 30 | Bioversys Ag Approves Election of Simona Skerjanec as Members of the Board of Directors | CI |
| Apr. 22 | BioVersys Completes Phase 1 Safety, Pharmacokinetic Trial for BV100 in China | MT |
| Market Cap | 153M 192M 166M 144M 269M 18.36B 274M 1.83B 708M 8.85B 720M 704M 30.77B | P/E Ratio 2026 * |
-4.55x | P/E Ratio 2027 * | -4.43x |
|---|---|---|---|---|---|
| Enterprise Value | 124M 155M 135M 116M 217M 14.87B 222M 1.48B 574M 7.17B 583M 570M 24.92B | EV / Sales 2026 * |
35.5x | EV / Sales 2027 * | 25.8x |
| Free-Float |
66.22% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioVersys AG
| 1 day | -2.96% | ||
| 1 week | -2.60% | ||
| Current month | -2.96% | ||
| 1 month | -1.50% | ||
| 3 months | +13.42% | ||
| 6 months | +11.97% | ||
| Current year | +7.38% |
| 1 week | 26.2 |  | 27.3 |
| 1 month | 26.2 | | 27.6 |
| Current year | 21.7 | | 30.7 |
| 1 year | 21.2 | | 36 |
| 3 years | 21.2 | | 37 |
| 5 years | 21.2 | | 37 |
| 10 years | 21.2 | | 37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Gitzinger
CEO | Chief Executive Officer | - | 2008-09-23 |
Hernan Levett
DFI | Director of Finance/CFO | 51 | 2023-10-31 |
Daniel Ritz
CTO | Chief Tech/Sci/R&D Officer | - | 2025-11-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Marc Gitzinger
BRD | Director/Board Member | - | 2008-09-23 |
Seng Chin Mah
CHM | Chairman | 66 | 2008-12-31 |
| Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Mar. 29 | Fiscal year | 469 | 0.0080% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.96% | -2.60% | -26.61% | - | 198M | |
| -1.40% | +0.12% | -14.73% | -12.58% | 43.68B | |
| +3.50% | -4.15% | +265.85% | +484.30% | 30.65B | |
| -0.61% | -3.11% | +14.00% | -12.36% | 30.4B | |
| -1.27% | -7.02% | -0.82% | +20.47% | 29.31B | |
| -0.66% | -5.84% | +7.59% | +12.76% | 24.2B | |
| +2.01% | +3.57% | +57.15% | +128.55% | 13.3B | |
| -1.65% | -1.08% | +7.92% | +7.56% | 13.21B | |
| +2.77% | -1.48% | - | - | 13.03B | |
| +0.68% | -1.74% | +103.98% | +81.60% | 12.12B | |
| Average | +0.04% | -1.55% | +46.04% | +88.79% | 21.01B | |
| Weighted average by Cap. | +0.11% | -1.65% | +51.81% | +89.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.5M 4.38M 3.8M 3.28M 6.13M 419M 6.26M 41.75M 16.16M 202M 16.43M 16.07M 702M | 6.05M 7.56M 6.56M 5.67M 10.59M 724M 10.81M 72.17M 27.94M 349M 28.39M 27.78M 1.21B |
| Net income | -32.94M -41.18M -35.74M -30.87M -57.68M -3.94B -58.88M -393M -152M -1.9B -155M -151M -6.61B | -34.05M -42.56M -36.93M -31.9M -59.6M -4.08B -60.85M -406M -157M -1.96B -160M -156M -6.83B |
| Net Debt | -29.2M -36.5M -31.68M -27.36M -51.12M -3.5B -52.19M -348M -135M -1.68B -137M -134M -5.86B | 2.63M 3.29M 2.86M 2.47M 4.61M 315M 4.71M 31.43M 12.17M 152M 12.36M 12.1M 529M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-11 | 26.20 CHF | -2.96% | 1,274 |
| 26-06-10 | 27.00 CHF | +2.66% | 541 |
| 26-06-09 | 26.30 CHF | -1.13% | 801 |
| 26-06-08 | 26.60 CHF | -2.56% | 6,171 |
| 26-06-05 | 27.30 CHF | +1.49% | 1,588 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIOV Stock
Select your edition
All financial news and data tailored to specific country editions
